Berberine Molecular Recognition of the Parallel MYC G-Quadruplex in Solution.


Journal

Journal of medicinal chemistry
ISSN: 1520-4804
Titre abrégé: J Med Chem
Pays: United States
ID NLM: 9716531

Informations de publication

Date de publication:
11 11 2021
Historique:
pubmed: 23 10 2021
medline: 1 2 2022
entrez: 22 10 2021
Statut: ppublish

Résumé

The medicinal natural product berberine is one of the most actively studied and pursued G-quadruplex (G4)-ligands. The major G-quadruplex formed in the promoter region of the MYC oncogene (MycG4) is an attractive drug target and a prominent example and model structure for parallel G-quadruplexes. G4-targeted berberine derivatives have been actively developed; however, the analogue design was based on a previous crystal structure in which berberine binds as a dimer to a parallel G-quadruplex. Herein, we show that in solution, the binding mode and stoichiometry of berberine are substantially different from the crystal structure: berberine binds as a monomer to MycG4 using a base-recruitment mechanism with a reversed orientation in that the positively charged convex side is actually positioned above the tetrad center. Our structure provides a physiologically relevant basis for the future structure-based rational design of G4-targeted berberine derivatives, and this study demonstrates that it is crucial to validate the ligand-DNA interactions.

Identifiants

pubmed: 34677968
doi: 10.1021/acs.jmedchem.1c01508
pmc: PMC8614230
mid: NIHMS1755706
doi:

Substances chimiques

Berberine 0I8Y3P32UF

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

16205-16212

Subventions

Organisme : NCI NIH HHS
ID : P30 CA023168
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA177585
Pays : United States
Organisme : NIGMS NIH HHS
ID : R37 GM045372
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA240346
Pays : United States

Références

FEBS Lett. 2019 Aug;593(16):2083-2102
pubmed: 31325371
Proteins. 2005 Jun 1;59(4):687-96
pubmed: 15815974
FEBS J. 2008 Aug;275(15):3971-83
pubmed: 18616467
Nucleic Acids Res. 2018 Nov 2;46(19):e115
pubmed: 29986058
Nat Commun. 2018 Oct 12;9(1):4229
pubmed: 30315240
Chemistry. 2021 Jun 10;27(33):8580-8589
pubmed: 33855748
Nucleic Acids Res. 2013 Jan 7;41(1):632-8
pubmed: 23104378
Genes Cancer. 2010 Jun;1(6):641-649
pubmed: 21113409
ACS Omega. 2019 Feb 28;4(2):2533-2539
pubmed: 30842981
J Am Chem Soc. 2019 Jul 17;141(28):11059-11070
pubmed: 31283877
Molecules. 2018 Jun 12;23(6):
pubmed: 29895786
Curr Protoc Nucleic Acid Chem. 2012 Sep;Chapter 17:Unit17.5
pubmed: 22956454
ACS Chem Biol. 2012 Jun 15;7(6):1109-19
pubmed: 22486369
Bioorg Med Chem. 2008 Aug 15;16(16):7582-91
pubmed: 18674916
J Magn Reson. 2003 Jan;160(1):65-73
pubmed: 12565051
J Am Chem Soc. 2011 Nov 9;133(44):17673-80
pubmed: 21967482
Nucleic Acid Ther. 2012 Apr;22(2):127-36
pubmed: 22480315
Nucleic Acids Res. 2019 Dec 16;47(22):11931-11942
pubmed: 31740959
Proc Natl Acad Sci U S A. 2017 Mar 14;114(11):E2136-E2145
pubmed: 28232513
J Nucleic Acids. 2010;2010:
pubmed: 20814427
Chem Asian J. 2016 Apr 5;11(7):1107-15
pubmed: 26865223
Nucleic Acids Res. 2011 Jul;39(Web Server issue):W511-7
pubmed: 21609950
Nucleic Acids Res. 2021 Jun 4;49(10):5905-5915
pubmed: 33978746
Nucleic Acids Res. 2020 Dec 2;48(21):12380-12393
pubmed: 33170272
Chemistry. 2015 Oct 5;21(41):14519-28
pubmed: 26272465
Nat Rev Drug Discov. 2011 Apr;10(4):261-75
pubmed: 21455236
ACS Med Chem Lett. 2020 Feb 07;11(5):645-650
pubmed: 32435365
J Chem Theory Comput. 2015 Dec 8;11(12):5723-36
pubmed: 26588601
J Chem Theory Comput. 2013 May 14;9(5):2339-2354
pubmed: 24058302
Bioorg Med Chem Lett. 2006 Mar 15;16(6):1707-11
pubmed: 16377184
Proc Natl Acad Sci U S A. 2002 Sep 3;99(18):11593-8
pubmed: 12195017
Molecules. 2021 Apr 28;26(9):
pubmed: 33924894
Chemistry. 2016 Feb 24;22(9):3170-81
pubmed: 26808655
Beilstein J Org Chem. 2020 Nov 18;16:2795-2806
pubmed: 33281983
J Chem Theory Comput. 2012 Jul 10;8(7):2506-2520
pubmed: 23197943
J Mol Recognit. 2015 Dec;28(12):722-30
pubmed: 26138009
Biochim Biophys Acta Gen Subj. 2017 May;1861(5 Pt B):1353-1361
pubmed: 28087374
Nucleic Acids Res. 2019 Jul 9;47(12):6098-6113
pubmed: 31114920
ACS Chem Biol. 2020 Apr 17;15(4):925-935
pubmed: 32216326
J Am Chem Soc. 2016 Mar 2;138(8):2563-70
pubmed: 26841249

Auteurs

Jonathan Dickerhoff (J)

Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University, 575 W Stadium Avenue, West Lafayette, Indiana 47904, United States.

Nicole Brundridge (N)

Department of Chemistry, Purdue University, 560 Oval Drive, West Lafayette, Indiana 47907, United States.

Scott A McLuckey (SA)

Department of Chemistry, Purdue University, 560 Oval Drive, West Lafayette, Indiana 47907, United States.

Danzhou Yang (D)

Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University, 575 W Stadium Avenue, West Lafayette, Indiana 47904, United States.
Department of Chemistry, Purdue University, 560 Oval Drive, West Lafayette, Indiana 47907, United States.
Purdue Center for Cancer Research, and Purdue Institute for Drug Discovery, West Lafayette, Indiana 47907, United States.

Articles similaires

Fucosyltransferases Drug Repositioning Molecular Docking Simulation Molecular Dynamics Simulation Humans
Nitriles Tensile Strength Materials Testing Gloves, Protective Product Packaging
Humans Breast Neoplasms Female Mass Spectrometry Adipose Tissue

The conformational landscape of fold-switcher KaiB is tuned to the circadian rhythm timescale.

Hannah K Wayment-Steele, Renee Otten, Warintra Pitsawong et al.
1.00
Rhodobacter sphaeroides Bacterial Proteins Circadian Rhythm Protein Folding Protein Conformation

Classifications MeSH